avoid repeated freezethaw cycles
For more on identity verification, see How to Read a Janoshik COA: HPLC, Mass Spec, and the Unique Key Explained
Retatrutides Phase 2 monotherapy weight loss (~24.2% at 48 weeks) is numerically larger than cagrilintides (~10.8% at 26 weeks), but those come from different trials, durations, and doses, and cagrilintides strongest data are as the CagriSema combination
It is supplied as a lyophilized powder for in vitro coordination-chemistry and biochemical assay work, including UV-Vis and circular dichroism metal-binding studies, potentiometric determination of stability constants, copper-dependent oxidoreductase assays, and use as a reference standard for reversed-phase HPLC, LC-MS, and ICP-MS copper determination